Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition.
ChemMedChem. 2022 Feb 4;17(3):e202100583. doi: 10.1002/cmdc.202100583. Epub 2021 Nov 18.
ChemMedChem. 2022.
PMID: 34761873
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity.
Nirogi R, Shinde A, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, Manchineella S, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, Jasti V.
Nirogi R, et al. Among authors: reballi v.
J Med Chem. 2019 Feb 14;62(3):1203-1217. doi: 10.1021/acs.jmedchem.8b01280. Epub 2019 Jan 25.
J Med Chem. 2019.
PMID: 30629436
Item in Clipboard
Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
Kambhampati R, Konda J, Reballi V, Shinde AK, Dubey PK, Nirogi RV.
Kambhampati R, et al. Among authors: reballi v.
J Enzyme Inhib Med Chem. 2008 Jun;23(3):302-12. doi: 10.1080/14756360701526936.
J Enzyme Inhib Med Chem. 2008.
PMID: 18569332
Item in Clipboard
Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P.
Nirogi R, et al. Among authors: reballi v.
J Med Chem. 2012 Nov 8;55(21):9255-69. doi: 10.1021/jm300955x. Epub 2012 Sep 28.
J Med Chem. 2012.
PMID: 23006002
Item in Clipboard
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease.
Nirogi R, Shinde A, Kambhampati RS, Mohammed AR, Saraf SK, Badange RK, Bandyala TR, Bhatta V, Bojja K, Reballi V, Subramanian R, Benade V, Palacharla RC, Bhyrapuneni G, Jayarajan P, Goyal V, Jasti V.
Nirogi R, et al. Among authors: reballi v.
J Med Chem. 2017 Mar 9;60(5):1843-1859. doi: 10.1021/acs.jmedchem.6b01662. Epub 2017 Feb 17.
J Med Chem. 2017.
PMID: 28212021
Item in Clipboard
Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists.
Nirogi RV, Bandyala TR, Reballi V, Konda JB, Daulatabad AV, Khagga M.
Nirogi RV, et al. Among authors: reballi v.
J Enzyme Inhib Med Chem. 2015 Feb;30(1):85-97. doi: 10.3109/14756366.2014.889126. Epub 2014 Mar 25.
J Enzyme Inhib Med Chem. 2015.
PMID: 24666297
Item in Clipboard
Cite
Cite